{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:16:58Z","timestamp":1793931418468,"version":"4.8.0"},"reference-count":104,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical writing support in line with Good Publishing Practice-3 guidelines was provided by Dr Kathy Croom on behalf of Content Ed Net, and was funded by Grifols"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Platelets"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/09537104.2022.2131751","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T09:27:01Z","timestamp":1667554021000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":92,"title":["Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib"],"prefix":"10.1080","volume":"34","author":[{"given":"Nichola","family":"Cooper","sequence":"first","affiliation":[{"name":"Imperial College London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Ghanima","sequence":"additional","affiliation":[{"name":"Oslo University","place":["Oslo, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-4358","authenticated-orcid":false,"given":"Quentin A","family":"Hill","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals","place":["Leeds, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-2975","authenticated-orcid":false,"given":"Phillip LR","family":"Nicolson","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust","place":["Birmingham, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Markovtsov","sequence":"additional","affiliation":[{"name":"Rigel Pharmaceuticals","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Kessler","sequence":"additional","affiliation":[{"name":"Georgetown University Medical Center","place":["Washington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00837-8"},{"key":"e_1_3_3_3_1","unstructured":"Tavlesse\u00ae (fostamatinib). Summary of Product Characteristics [accessed 2021 Sep 19]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tavlesse-epar-product-information_en.pdf."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2040014"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05190-z"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2765"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107168"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00803-4"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm201271b"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0082-8"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2014.05.007"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0215"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.109058"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.03.543"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009030263"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-166439"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V106.11.2165.2165"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27452"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000983"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.230847"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv114"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.1"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1268"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1027"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.6.2385"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211010875"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04470.x"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03451.x"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300672"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306883"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-360743"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01169"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00218-6"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00454-7"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2020.100742"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-03029-y"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"issue":"11","key":"e_1_3_3_39_1","first-page":"e138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo Y","year":"2020","unstructured":"Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair C, Weber A, Barnes BJ, Egeblad M. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999","journal-title":"JCI Insight"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00311"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.7.4209"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02867"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab466.759"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.12.062"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf8654"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.01.442279"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa789"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100137"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100145"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241742"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081876"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031994"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00331-3"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101643"},{"key":"e_1_3_3_56_1","unstructured":"Food and Drug Administration. FDA requires warnings about increased risk of serious heart-related events cancer blood clots and death for JAK inhibitors that treat certain chronic inflammatory conditions. 2021 [accessed 2021 Nov 20]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.13.190140"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03875.x"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.26.437014"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02134-3"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4294"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X20932640"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-274969"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15783"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1746199"},{"key":"e_1_3_3_69_1","first-page":"383104","article-title":"Peripheral thrombosis and necrosis after minimally invasive redo mitral valve replacement due to unknown etiology: difficult diagnosis of heparin induced thrombocytopenia","volume":"2015","author":"Nakamura Y","year":"2015","unstructured":"Nakamura Y, Bainbridge DT, Kiaii B. Peripheral thrombosis and necrosis after minimally invasive redo mitral valve replacement due to unknown etiology: difficult diagnosis of heparin induced thrombocytopenia. Case Rep Vasc Med. 2015;2015:383104","journal-title":"Case Rep Vasc Med"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X17714340"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400478"},{"key":"e_1_3_3_72_1","unstructured":"Tavalisse\u00ae (fostamatinib). US Prescribing Information [accessed 2021 Nov 19]. https:\/\/tavalisse.com\/downloads\/pdf\/Tavalisse-Full-Prescribing-Information.pdf"},{"key":"e_1_3_3_73_1","unstructured":"ClinicalTrials.gov. The safety tolerability pharmacokinetics and preliminary efficacy of HMPL-523 in Immune Thrombocytopenia Patients [accessed 2021 Nov22]. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03951623"},{"key":"e_1_3_3_74_1","unstructured":"ClinicalTrials.gov. Study of Oral SKI-O-703 SYK inhibitor in patients with persistent and chronic Immune Thrombocytopenia (ITP). [accessed 2021 Nov 22]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04056195"},{"key":"e_1_3_3_75_1","unstructured":"ClinicalTrials.gov. Phase III study on HMPL-523 for treatment of ITP. [accessed 2022 Apr 15]. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05029635"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25444"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16959"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25125"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"e_1_3_3_80_1","unstructured":"ClinicalTrials.gov. Observational study of Fostamatinib as second line therapy in adult patients with Immune Thrombocytopenia (ITP) and insufficient response to a prior therapy. [accessed 2022 April 15]. https:\/\/www.clinicaltrials.gov\/ct2\/show\/record\/NCT04904276"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.018390"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-748707"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03830.x"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15573"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103581"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1159\/000520438"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136982"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236471"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.10.005"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e20067"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-595934"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1064"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716636542"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140238"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3482-7"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000500"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23992"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.768980"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26508"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140469"},{"issue":"1","key":"e_1_3_3_101_1","first-page":"932","article-title":"Update on the phase 3 clinical trial of fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia (wAIHA)","volume":"137","author":"Piatek C","year":"2021","unstructured":"Piatek C, Cooper N, Zhou X. Update on the phase 3 clinical trial of fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia (wAIHA). Blood. 2021;137(Supplement 1):932","journal-title":"Blood"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab732"},{"key":"e_1_3_3_103_1","unstructured":"ClinicalTrials.gov. Novel Experimental COVID-19 Therapies Affecting Host Response (NECTAR). [accessed 2022 Feb 1]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04924660."},{"key":"e_1_3_3_104_1","unstructured":"ClinicalTrials.gov. A Phase 3 multi-center randomized double-blind placebo-controlled study of Fostamatinib Disodium in the treatment of wAIHA. [accessed 2022 April 15 2022]. https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=&term=NCT03764618."},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2021.12.5.6"}],"container-title":["Platelets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09537104.2022.2131751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:19:54Z","timestamp":1760948394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09537104.2022.2131751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/09537104.2022.2131751"],"URL":"https:\/\/doi.org\/10.1080\/09537104.2022.2131751","relation":{},"ISSN":["0953-7104","1369-1635"],"issn-type":[{"value":"0953-7104","type":"print"},{"value":"1369-1635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iplt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iplt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2131751"}}